RecruitingNCT06065982

Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT)

Prospective Observational Cohort Study on the Outcomes of Percutaneous Inserted PD Catheters


Sponsor

Universitair Ziekenhuis Brussel

Enrollment

500 participants

Start Date

Jun 23, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Peritoneal dialysis (PD) is the most frequent modality of home dialysis for patients with kidney failure. Most PD catheters are placed using a laparoscopic technique. This approach requires the availability of a qualified surgeon, time in the operating theater and general anaesthesia for the patient. Thus, the laparoscopic technique is less suitable for patients with severe heart failure or multimorbidity where general anaesthesia is not possible. PD catheters can also be inserted using a percutaneous strategy using a modified Seldinger technique. This strategy can be performed bedside under local anaesthesia, by the nephrologist, radiologist, a surgeon, physician assistant or qualified nurse. The availability of the percutaneous implantation strategy of a PD catheter in a nephrology center may accomodate more patients to receive a PD catheter insertion, including those who have a contraindication to general anaesthesia or need urgent PD. The PREDICT project aims to increase knowledge and competencies on percutaneous PD catheter insertions by training centers for this technique. By establisching a prospective registry, the outcomes of percutaneously inserted PD catheters, both in experienced and newly trained centers, will be assessed.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study (called PREDICT) collects data on patients who have a catheter inserted through the skin to perform peritoneal dialysis — a type of kidney dialysis done at home through the abdomen. The goal is to understand outcomes and complications of this catheter insertion procedure. **You may be eligible if...** - You are over 18 years old - You have had or are scheduled to have a peritoneal dialysis catheter inserted between March 2023 and March 2026 - You can be enrolled up to 4 weeks before or 12 weeks after catheter insertion **You may NOT be eligible if...** - You are unable to give informed consent - Your life expectancy is less than 3 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaires

Health-related quality of life will be measured using the 12-item Short Form (SF-12) and EQ5D-5L questionnaires. The SF-12 is summarized into two component scores, the Physical Component Score (PCS) and Mental Composite Score (MCS).


Locations(2)

Universitair Ziekenhuis Brussel

Brussels, Belgium

UMC Utrecht

Utrecht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06065982


Related Trials